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Abstract
Background: It is not known whether or not delivering acupuncture triggers mechanisms cited as placebo and if
acupuncture or sham reduces radiotherapy-induced emesis more than standard care.
Methodology/Principal Findings: Cancer patients receiving radiotherapy over abdominal/pelvic regions were randomized
to verum (penetrating) acupuncture (n=109; 99 provided data) in the alleged antiemetic acupuncture point PC6 or sham
acupuncture (n=106; 101 provided data) performed with a telescopic non-penetrating needle at a sham point 2–3 times/
week during the whole radiotherapy period. The acupuncture cohort was compared to a reference cohort receiving
standard care (n=62; 62 provided data). The occurrence of emesis in each group was compared after a mean dose of 27
Gray. Nausea and vomiting were experienced during the preceding week by 37 and 8% in the verum acupuncture group, 38
and 7% in the sham acupuncture group and 63 and 15% in the standard care group, respectively. The lower occurrence of
nausea in the acupuncture cohort (verum and sham) compared to patients receiving standard care (37% versus 63%,
relative risk (RR) 0.6, 95 % confidence interval (CI) 0.5–0.8) was also true after adjustment for potential confounding factors
for nausea (RR 0.8, CI 0.6 to 0.9). Nausea intensity was lower in the acupuncture cohort (78% no nausea, 13% a little, 8%
moderate, 1% much) compared to the standard care cohort (52% no nausea, 32% a little, 15% moderate, 2% much)
(p=0.002). The acupuncture cohort expected antiemetic effects from their treatment (95%). Patients who expected nausea
had increased risk for nausea compared to patients who expected low risk for nausea (RR 1.6; Cl 1.2–2.4).
Conclusions/Significance: Patients treated with verum or sham acupuncture experienced less nausea and vomiting
compared to patients receiving standard care, possibly through a general care effect or due to the high level of patient
expectancy.
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Introduction
Many cancer patients express interest in acupuncture for nausea
[1-2] but it is not known if acupuncture is more effective for emesis
(nausea and vomiting) than standard care during radiotherapy.
Approximately 60% of patients irradiated over abdominal and/or
pelvic fields experienced emesis during radiotherapy [1,3–4].
Antiemetics are effective, especially serotonin-receptor antagonists
combined with corticosteroids [5]. However, some patients at risk
for nausea do not receive potent antiemetics, do not respond
satisfactorily [1,3,5], or experience side-effects [5]. In a previous
study we found that of 145 nauseous patients irradiated over a
variety of regions, one third asked for more treatment against
nausea while 40% rejected antiemetics [1].
Between two and 31% of patients undergoing cancer treatment
use acupuncture for various kinds of symptoms [2]. In chemo-
therapy-induced nausea, acupuncture and acupressure reduced
nausea more than antiemetics, but those studies did not include
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e14766any sham treated control groups [6–11]. In a study of 80
chemotherapy patients, penetrating acupuncture did not reduce
nausea more than telescopic non-penetrating sham needles [12].
In our study of radiotherapy-induced nausea, 70% of patients
randomized to penetrating acupuncture and 62% of patients
treated with telescopic sham needles experienced nausea during
the radiotherapy period [13]. Apparently there was a lack of effects
that could be related to the specific characteristics of verum
(genuine) acupuncture; i.e. stimulation of skin penetrating needles
in traditional acupuncture points resulting in a ‘‘deqi’’ sensation.
However, as many as 95% of patients in both groups considered the
treatment to be effective, and 89% were interested in receiving the
treatments in the future [13]. In the light of the apparent conflict
between lack of specific effects from verum acupuncture and large
subjectively experienced positive effects it seems interesting to
evaluate if acupuncture has antiemetic effects related to nonspe-
cific mechanisms.
The aims of the study were to compare nausea and vomiting
experienced by a cohort treated with verum or sham acupuncture
with that experienced by a cohort receiving standard care during
radiotherapy, and to evaluate if expectations of nausea and of
acupuncture effects were related to the actual occurrence of
nausea.
Materials and Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Protocol S1 and
Checklist S1.
Inclusion
Two cohorts of patients treated for cancer in three Swedish
oncology departments were included: one a standard care and the
other an acupuncture cohort, see figure 1. The standard care
cohort was created by a cross-sectional selection in four different
days at two oncology departments in 1999 and 2003 [1] (n=62).
The acupuncture cohort was created from consecutively included
patients in 2004 to 2006 at one of the two oncology departments
referred to above and also in another oncology department [13].
Members of this cohort were randomized to verum acupuncture
(n=109) or sham acupuncture (n=106). Inclusion criteria for
both cohorts were that patients were at least 18 years of age, had
radiotherapy over abdominal or pelvic fields and were able to take
part in the study procedure. Exclusion criteria for the acupuncture
cohort only were radiotherapy of less than 800 cm
3 volume and 25
Gray dose, antiemetic treatment or persistent nausea within 24
hours prior to the start of radiotherapy and acupuncture treatment
during the past year for any indication or ever for nausea.
All patients gave their informed written consent and the
Regional Ethical Review Board in Linko ¨ping, Sweden, approved
the study. The informed consent form used in the acupuncture
cohort contained the information: ‘‘You will receive an ordinary
acupuncture treatment with needles penetrating the skin or
another treatment with needles placed just against the skin’’.
The study-evaluator and all health-care professionals, with the
exception of the acupuncture-providing therapists, were blind to
the acupuncture allocation. The standard care group knew, of
course, that no acupuncture was given. They had been informed
that the aim of the data collection was to evaluate the prevalence
of nausea during radiotherapy.
Treatment regimens
The acupuncture and the standard care cohort were, except for
study participation, treated according to clinical routines,
including the use of rescue antiemetics. The standard care cohort
received no acupuncture therapy. One physiotherapist at each
hospital (performing 1412 and 607 treatments) performed both
verum and sham acupuncture and they had five deputy
physiotherapists (performing 228, 75, 54, 32 and 6 treatments).
Treatments started on the first day of radiotherapy, continued 30
minutes per session three times/week for two weeks, and then
twice/week, until the end of radiotherapy according to a
standardised treatment protocol. The patients were in a hotel,
ward unit or at the radiotherapy department during the
treatments, received either in a sitting or a supine position. The
physiotherapists treated one to three patients simultaneously and
maintained an everyday conversation, but avoided the subject of
nausea.
Verum acupuncture was administered bilaterally to the tradi-
tional antiemetic point pericardium six (PC6) [14] between the
tendons of palmaris longus and flexor carpii radialis at two body-
inches proximal of the wrist crease. Sharp needles, diameter 0.30
6length 40 millimetres, were inserted into a depth of a half body-
inch. One body-inch (or a ‘‘cun’’: approximate 1.5 cm) is
equivalent to the greatest width of the individual patient’s thumb
at the distal phalanx. The needles were manipulated three times/
treatment by twirling and lifting until ‘‘deqi’’ occurred. ‘‘Deqi’’ is
the specific sensation of verum acupuncture, involving heaviness,
numbness, soreness and a minimal muscular contraction around
the needle [15].
Sham acupuncture was administered bilaterally to a sham point
located two body-inches proximal to PC6, outside traditional
acupuncture points. ‘‘Park’s sham devise’’ [16], 0.30640 millime-
tres (extended length) was used. The credible [13] blunt telescopic
needle glides upwards into its handle instead of penetrating the
skin, and thus gives the illusion of penetration. Double-sticky
marking tubes, used in both groups, held the sham needles in
place. The therapists manipulated the sham needles three times/
session until the needles touched the skin, but no ‘‘deqi’’ occurred.
The duration of needle pressure to the skin was approximately ten
seconds/session.
Data collection
Background data. Clinical data, listed in table 1, were
extracted from the patients’ medical records. Other background
variables, listed in table 2, were collected in a written
questionnaire.
Nausea, vomiting and use of antiemetics. Type/dose of
antiemetics and emesis during the previous 24-hours were
measured by written established emesis questions [1,17]: ‘‘Have
you experienced nausea?’’, answered on a four-level category
scale: ‘‘No, not at all’’ or ‘‘Yes, a little/moderate/much’’ and
‘‘Have you been vomiting?’’ answered by ‘‘No’’ or ‘‘Yes’’. In the
acupuncture cohort the questions were asked daily during the
whole radiotherapy period. In the standard care cohort, the
questions were asked only once (after a mean dose of 27 Gray of
radiotherapy) and at that time the questions were asked regarding
the previous 24 hours and also within the time frame of the
preceding week. Every patient who had experienced nausea at
least once within the preceding seven days (irrespective of
intensity) or vomiting was assigned to the groups ‘‘Experiencing
nausea’’ or ‘‘Experiencing vomiting’’. The emesis questions
showed in pilot studies satisfactory face-validity (n=9), construct
validity (Spearman’s correlation coefficient (r) 1.0; n=456 paired
observations) and test-retest reliability (r 0.98–1.0; n=36).
Expectations of treatment effects and on nausea. At the
end of the first, the sixth and the last verum or sham treatment the
physiotherapists asked the patients: ‘‘Do you believe that the
Nonspecific Treatment Effects
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reducing nausea?’’ The four answer categories were ‘‘No, I do not
think the treatment is effective’’ and ‘‘Yes, I believe a little/
moderately/much that the treatment is effective’’. Before
treatment was started, the verum and sham treated patients
answered the written question: ‘‘In relation to others, how do you
estimate your own risk for becoming nauseous during the
radiotherapy period?’’ to be answered on a five-grade category
scale from ‘‘Much lower risk’’ to ‘‘Much higher risk’’.
Statistical analysis
The acupuncture cohort was compared with the standard care
cohort using Student’s t-test regarding continuous data, Mann
Whitney U-test regarding ordinal or continuous, not normally
distributed, data and by Fisher’s exact (two categories), or Chi2-
test (three categories or more), regarding category data. Relative
risk (RR) for nausea with 95% confidence intervals (CI) was
calculated for each of the different subgroups shown in table 1 and
table 2 as compared to a reference group (RR 1.0), defined as the
subgroup with the lowest prevalence of nausea. One exception was
made; the subgroup of patients believing ‘‘little’’ in antiemetic
effects of verum/sham treatment was not chosen as a reference
group, because it consisted of only ten patients. A multivariable
logistic regression model was constructed to determine the relative
importance of the different characteristics seen in and table 2 1 for
explaining the occurrence of nausea (Logistic procedure, forward
selection) and the RR for nausea was adjusted in proc Genmod,
with a log link and binomial error distribution. At the time that
Figure 1. Selection of the patients in the standard care and the acupuncture cohort.
doi:10.1371/journal.pone.0014766.g001
Nonspecific Treatment Effects
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standard care cohort was compared with the acupuncture cohort
regarding occurrence of nausea and vomiting. SPSS for Windows
(version 15.0.0) was used, except for calculating adjusted RR risks
for nausea where we used SAS (version 9.1.3.). The significance
level was set as p,0.05.
Results
Participants
Compared to the acupuncture cohort the standard care cohort
comprised more men (p=0.02), more patients with a testicular
tumour (p=0.001) and fewer patients consuming potent anti-
emetics; serotonin-receptor antagonists (p=0.09) or corticosteroids
(p,0.001) (table 1). According to the univariable analysis, nausea
was not related to gender (table 2) but was more frequent in
patients with testicular tumours and in patients treated with
serotonin-receptor antagonists or corticosteroids (table 1). In the
multivariable analysis, concomitant chemotherapy (p=0.01,
table 1), age less than 40 years (p,0.001), previous nausea in
any situation (p,0.001) and a self estimated risk for nausea as
higher than others during radiotherapy (p=0.01) all indicated a
significantly increased risk for nausea (table 2).
Emesis in the verum, sham and standard care group
The patients in the acupuncture cohort the past week and the
past 24 hours experienced significantly less occurrence of nausea
and vomiting than those in the standard care cohort. The lower
occurrence of nausea in the acupuncture cohort (37%) compared
to the standard care cohort (63%) the past week (RR 0.6, CI 0.45–
0.77) was also true when patients taking serotonin-receptor
antagonists and corticosteroids were excluded (figure 2) and after
adjustment for confounding factors for nausea (table 3).
The intensity of nausea was lower in the acupuncture cohort (n
140; 78% experienced no nausea, n=24; 13% a little nausea,
n=14; 8% moderate nausea and n=2; 1% much nausea) than in
Table 1. Clinical characteristics of the patients in the verum acupuncture, sham acupuncture or standard care group.
Characteristics Acupuncture cohort n=215
Standard care
cohort n=62
Experiencing
nausea n=
172/total n
providing
data=267
1
Univariable
relative risk
(95 % confi-
dence interval)
Multivariable2
relative risk,
(95 % confidence
interval) adjusted
for three groups
Verum acupun-
cture n=109
Sham
acupuncture
n=106
Tumor diagnose, n (%) n=109 n=106 n=62 n=267
Gynecological- 72 (66) 75 (71) 37 (60) 111/178 (62) 1.0 (Ref.) 1.0 (Ref.)
Colon-/rectal- 31 (28) 29 (27) 11 (18) 43/67 (64) 1.0 (0.8–1.3) 1.0 (0.8–1.3)
Testicular- 2 (2) 0 (0) 6 (10) 7/8 (88) 1.4 (1.1–1.8) 1.5 (1.0–2.2)
Pancreas, stomach or
gallbladder-tumor
4 (4) 2 (2) 8 (13) 11/14 (79) 1.3 (0.9–1.7) 1.3 (0.9–1.9)
Total radiotherapy dose
(Gray) mean 6 SD
47.9 610.7 50.3 6 10.3 41.8 6 10.0 47.3 6 10.5
Concomitant
chemotherapy, n (%)
n=100 n=99 n=61 n=260
Yes 28 (28) 29 (29) 15 (25) 57/72 (79) 1.3 (1.1–1.6) 1.3 (1.1–1.6)
No 72 (72) 70 (71) 46 (75) 112/188 (60) 1.0 (Ref.) 1.0 (Ref.)
Consumption of
antiemetics at least
once, n (%)
n=100 n=101 n=62 n=263
No 67 (67) 69 (68) 36 (58) 74/162 (46) 1.0 (Ref) 1.0 (Ref)
Any type 42 (42) 37 (37) 26 (42) 98/105 (93) 2.1 (1.7–2.4) 2.0 (1.7–2.4)
Serotonin-receptor
antagonists
21 (21) 23 (23) 7 (11) 48/51 (94) 2.1 (1.7–2.5) 1.6 (1.2–2.0)
Dopamine-receptor
antagonists
24 (24) 21 (21) 6 (10) 48/51 (94) 2.1 (1.7–2.5) 2.1 (1.7–2.6)
Corticosteroids 13 (13) 25 (25) 1 (2) 34/39 (87) 1.9 (1.6–2.3) 1.9 (1.5–2.3)
Antihistamines or
neuroleptics
12 (12) 9 (9) 18 (29) 37/39 (95) 2.1 (1.7–2.5) 1.6 (1.3–2.0)
Medication for any other
illness/symptom, n (%)
n=99 n=100 n=62 n=261
Yes 80 (80) 88 (88) 40 (65) 140/208 (67) 1.2 (0.9–1.5) 1.2 (0.9–1.6)
No 19 (19) 12 (12) 22 (35) 30/53 (57) 1.0 (Ref.) 1.0 (Ref.)
Numbers (n) of patients answering the questions are presented,
1267 of 277 patients provided data regarding nausea. Experiencing nausea was defined as any day
within the radiotherapy period in the acupuncture cohort and within the past week in the standard care cohort.
2Including the variables seen in table 1 and 2.
SD=Standard Deviation.
doi:10.1371/journal.pone.0014766.t001
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Characteristics Acupuncture cohort n=215
Standard care
cohort n=62
Experiencing
nausea n=172/
total n providing
data=267
1
Univariable
relative risk
(95 % confidence
interval)
Multivariable
2
relative risk, (95 %
confidence interval)
adjusted for three
groups
Verum
acupuncture
n=109
Sham acupun-
cture n=106
Sex, n (%) n=109 n=106 n=62 n=267
Man 20 (18) 15 (14) 19 (31) 35/53 (66) 1.0 (0.8–1.3) 1.0 (0.8 1.3)
Woman 89 (82) 91 (86) 43 (69) 137/214 (64) 1.0 (Ref.) 1.0 (Ref.)
Age in years: mean 6 SD 64 6 13.8 63 613.9 63 6 14.5 62 6 14.8
19–40 7 (6) 6 (6) 6 (10) 17/19 (89) 1.5 (1.2–1.8) 1.5 (1.2–2.0)
41–60 34 (31) 34 (32) 17 (27) 55/82 (67) 1.1 (0.9–1.4) 1.1 (0.9–1.3)
61–89 68 (62) 66 (62) 39 (63) 98/164 (60) 1.0 (Ref.) 1.0 (Ref.)
Labor status, n (%) n=106 n=104 n=62 n=257
Employed 35 (33) 41 (38) 21 (34) 65/94 (69) 1.2 (1.0–1.0) 1.2 (1.0–1.4)
Retired/Sickness pension 69 (65) 59 (57) 26 (42) 82/142 (58) 1.0 (Ref.) 1.0 (Ref.)
Other 2 (2) 4 (4) 15 (24) 18/21 (86) 1.5 (1.2–1.9) 1.6 (1.1–2.1)
Previous nausea, n (%)
During previous chemotherapy n=96 n=97 n=62 n=256
Not relevant 55 (57) 58 (60) 43 (69) 95/155 (61) 1.0 (0.8–1.4) 1.0 (0.8–1.4)
No 11 (11) 12 (12) 15 (24) 23/39 (59) 1.0 (Ref.) 1.0 (Ref.)
Yes 30 (31) 28 (29) 4 (6) 47/62 (76) 1.3 (1.0–1.7) 1.3 (0.9–1.7)
During pregnancy n=89 n=92 n=61 n=242
Not relevant 26 (29) 28 (30) 33 (54) 56/87 (64) 1.3 (0.9–1.7) 1.3 (1.1–1.9)
No 19 (21) 24 (26) 6 (10) 25/49 (51) 1.0 (Ref.) 1.0 (Ref.)
Yes 44 (49) 40 (43) 22 (36) 78/106 (74) 1.4 (1.1–1.9 1.4 (1.1–1.9)
In any previous situation
3 n=96 n=98 n=61 n=256
No 22 (23) 29 (30) 17 (27) 30/74 (41) 1.0 (Ref.) 1.0 (Ref.)
Yes 74 (77) 69 (70) 44 (72) 134/182 (74) 1.8 (1.4–2–4) 2.0 (1.3–3.3)
N of previous nausea situations
3,
md (25th–75th percentile)
n=97
2
(1–3)
n=98
2
(1–3)
n=61
2
(0–3)
n=257
2
(1–3)
0–2 situations 68 (70) 67 (68) 44 (71) 110/179 (61) 1.0 (Ref.) 1.0 (Ref.)
3–5 situations 29 (30) 31 (32) 18 (29) 56/78 (72) 1.2 (1.0–1.4) 1.2 (1.0–1.4)
Patients’ estimation of risk for
nausea, n (%)
n=89 n=94 not mea-sured n=183 not relevant
Lower than others 19 (21) 25 (27) 22/44 (50) 1.0 (Ref.)
Similar to others 57 (64) 55 (59) 73/112 (65) 1.3 (1.0–1.9)
Higher than others 13 (15) 14 (15) 22/27 (81) 1.6 (1.2–2.4)
Expectation of antiemetic
treatment effects, n (%)
n=105 n=105 not mea-sured n=201 not relevant
Do not believe 0 (0) 0 (0) 0/0 (0)
Believe little 5 (5) 6 (6) 4/10 (40) 0.64 (0.3–1.4)
Believe moderately 50 (46) 57 (54) 70/102 (68) 1.1 (0.9–1.3)
Believe much 50 (46) 42 (40) 56/89 (62) 1.0 (Ref)
Previous experience of
acupuncture
4, n (%)
n=109 n=101 not mea-sured n=209 not relevant
Yes 36 (33) 36 (34) 47/72 (65) 1.1 (0.6–1.3)
No 73 (66) 65 (62) 82/137 (60) 1.0 (Ref)
Numbers (n) of patients answering the questions are presented,
1267 of 277 patients provided data regarding nausea. Experiencing nausea was defined as any day
within the radiotherapy period in the acupuncture cohort and within the past week in the standard care cohort.
2Including the variables seen in table 1 and 2.
3In
travelling, unpleasant smells/sights, anxiety, chemotherapy or pregnancy.
4For other conditions than emesis. SD=Standard Deviation. Md=Median.
doi:10.1371/journal.pone.0014766.t002
Nonspecific Treatment Effects
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little, n 9; 15% moderate and n 1; 2% much) (p=0.002). Within
the acupuncture cohort, no statistically significant differences
between the verum and the sham group were seen regarding
nausea occurrence or intensity, vomiting or antiemetic consump-
tion the past 24 hours or the past week.
Expectations of nausea and the effects of treatment in
the verum and sham acupuncture groups
The 27 patients in the acupuncture cohort who estimated their
own risk for becoming nauseous during the radiotherapy as higher
than other patients had an increased risk for nausea compared to
the 44 patients who estimated that they had a lower risk for nausea
than others (table 2). No statistically significant differences in
baseline expectations of antiemetic treatment effects were seen
between the patients who experienced nausea and the patients
who stayed free from nausea during the radiotherapy period
(table 2). The patients who experienced nausea between the sixth
and last treatments either retained or decreased their original
belief in the antiemetic effects of the received treatment. The
patients who stayed free from nausea either retained their original
belief that the treatment would help or even reported an increase
in the extent to which they trusted this treatment (figure 3). Of the
patients mostly treated by therapist A (performing 1412 of 1700
treatments, 83%), 20 of 69 (29%) in the verum acupuncture group
and 25 of 76 (33%) in the sham acupuncture group experienced
nausea the past week. In the patients mostly treated by therapist B
(performing 607 of 693 treatments, 87%), corresponding figures
were 13 of 41 (32%) and 10 of 29 (35%), respectively.
Discussion
We found lower occurrence of nausea and vomiting in patients
treated with penetrating ‘‘deqi’’-creating acupuncture or sham
acupuncture compared to patients who had received standard
Figure 2. Nausea and vomiting within the past 24 hours and the past week. Emesis was measured at that time the radiotherapy dose was
27 Gray (mean) in the verum, sham and standard care groups. Measured in all patients and in patients not receiving potent antiemetics in the verum
(n=88 and n=77), sham (n=95 and n=78) and standard care group (n=62 and n=55).
doi:10.1371/journal.pone.0014766.g002
Table 3. Comparison of nausea occurrence between the
standard care cohort and the acupuncture cohort, adjusted
for confounding factors for nausea.
Nausea occurrence
the past week
Acupuncture cohort
1, number (%) n=183 68 (37)
Standard care cohort, number (%) n=62 39 (63)
Relative Risk, unadjusted (95 % Confidence
Interval)
0.6 (0.5–0.8)
Relative Risk, adjusted for concomitant
chemotherapy (95 % Confidence Interval)
0.3 (20.7–0.7)
Relative Risk, adjusted for age (95 %
Confidence Interval)
0.4 (20.1–0.8)
Relative Risk, adjusted for nausea in
previous situations (95 % Confidence Interval)
0.3 (20.2–0.7)
Relative Risk, overall adjustment
2 (95 %
Confidence Interval)
0.8 (0.6–0.9)
Relative risks for nausea (prevalence acupuncture cohort/ standard care cohort)
during a cross sectional week of radiotherapy (mean dose 27 Gray in both
cohorts).
1Verum and sham treated patients.
2Overall adjustment included
adjustment for concomitant chemotherapy, age and nausea in any previous
situation.
doi:10.1371/journal.pone.0014766.t003
Nonspecific Treatment Effects
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expected antiemetic effects from the treatment. Patients who
expected nausea had increased risk for nausea compared to
patients who expected low risk for nausea.
There are many, not sham-controlled studies, reporting emesis-
reducing effects of acupuncture compared to standard care in
chemotherapy-induced nausea [14]. Our results indicate that
nonspecific factors such as the extra care or the high expectations
of positive treatment effects, not the specific characteristics of
verum acupuncture, reduced emesis. Alternatively, the findings
could result from flaws in our non-randomized design. Since the
patients were not randomized to standard care, we investigated if
an imbalance of confounding factors possibly contributing to
emesis may have explained the higher prevalence of emesis in the
standard care group, according to the hierarchical step model
[18]. The higher risk for nausea in the standard care cohort was
valid also after adjusting for possible confounding factors for
emesis and after omitting patients taking serotonin-receptor
antagonists and corticosteroids, indicating that our findings are
valid. We have not identified any previous study of the effect of
verum or sham acupuncture compared to standard care on
radiotherapy-induced emesis (Pubmed, http://www.ncbi.nlm.nih.
gov/ pubmed/accessed 10/11/10, using the combined search
terms acupuncture, radiotherapy, nausea and vomiting). A
Cochrane review of acupuncture for chemotherapy-induced
nausea included eleven studies [14]. Only two sham-controlled
studies were reported, one positive (n=104) [19] and one negative
(n=80) [12], except for a pilot study including only 10 patients
[20]. As concerns conditions in general, there exist positive sham
controlled studies, but there are also indications that the effect of
acupuncture may not be related to the specific characters of verum
acupuncture. In line with our results, Haake and co-workers [21]
found substantial improvement of back pain in 48% of 387
patients treated by verum acupuncture, in 44% of 387 patients
treated with sham and in 27% of 388 patients receiving standard
care. In other studies sham acupuncture reduced musculoskeletal
arm pain significantly more than verum acupuncture [22].
The verum and the sham group received extra care compared
to the standard care group, which may have reduced emesis:
patient-therapist communication, the knowledge that continuous
contact with one single therapist would continue during the whole
radiotherapy period, the tactile stimulation from the therapists’
hands, the extra time for rest and relaxation and the extra
attention to the patient’s symptoms through the daily emesis
Figure 3. Trust in the effect of the received treatment for preventing and reducing nausea. The trust was stated at the sixth and the last
verum or sham treatment in patients free from nausea and patients experiencing nausea after the sixth verum or sham treatment. Number of
patients rating trust in antiemetic effects of received treatment at both the sixth and the last session was 183.
doi:10.1371/journal.pone.0014766.g003
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and sham performing therapists in our study might have had a
supportive attitude. Arving and co-workers [23] found that
chemotherapy patients who received supportive conversations
reported higher quality of life and less nausea than did patients
receiving standard care. Bo ¨rjeson and co-workers [24] also found
that chemotherapy patients who received extra care comprising
information and relaxation training increased their well-being
compared to patients receiving antiemetics only, despite the fact
that the extra-care group received a less optimal antiemetic
treatment.
Both verum acupuncture and sham-acupuncture like tactile
stimulation have been seen to activate the limbic system [15]; did
the low dose of sensory stimulation at the non-acupuncture point
reduce emesis? Kaptchuk and co-workers [25] implied that the
patient-therapist meeting was more important than the needle
stimulation.Of87patients who receivedshamacupuncturefrom an
emphatic committed therapist 62% reported adequate symptom
relief of irritable bowel symptoms, compared to 44% of 88 patients
receiving sham acupuncture from a non-communicating therapist
and 28% of 87 patients on waiting list. The verum and shamtreated
patients in our study received extra time for rest and relaxation and
slightly more body-contact than the standard care patients, which
may have reduced distress. Psychological distress has been seen as a
predictor for emesis [26] and studies indicate that relaxation [27] as
well as body-contact (tactile stimulation, massage) [28] may reduce
nausea in cancer patients.
Since almost all patients in the acupuncture cohort expected
positive antiemetic effects of the treatment, the positive expectation
may be another factor that reduced emesis. Expectations are known
to influence intervention outcomes in general [29]. Indeed, Pariente
and co-workers [30] found with the use of positron emission
tomography (PET) that when individuals were informed that the
blunt sham needle they were treated with was ineffective, no activity
in the pain modulating areas in the mid-brain was seen. When a
credible telescopic sham needle was used that the individuals
believed was effective, a large pain-modulating activity was seen.
Likewise, Linde and co-workers [31] found that acupuncture and
sham treated patients with headache, chronic low back pain or
osteoarthritis who had high expectations on pain-reduction
reported better effects than patients with low expectations. In our
study there were no differences in the occurrence of nausea between
the patients who believed in the antiemetic effects of treatment and
those who had a lesser belief in the antiemetic effects of treatment.
Either expectations about the treatment effect were not important
for nausea, or the category scale used was not sufficiently sensitive,
thus resulting in a ‘‘roof effect’’. The patients’ trust in the antiemetic
effect of verum or sham acupuncture decreased if nausea occurred
and increased if nausea did not occur. This finding is in
concordance with results from experiments indicating that the
placebo response is a short-time effect; for example if a noxious
stimulation is performed after taking a placebo pill, the study subject
no longer believes in the effect of the placebo pill [29]. In our study,
patients who expected nausea apparently had an increased risk for
nausea, in concordance with findings regarding chemotherapy-
induced nausea [32]. Thus, patients are either capable of judging
theirownriskfornauseaorthe negativeexpectationsperseproduce
nausea. This finding implies that health care professionals might
well consider asking the patients about their expectations about
experiencing nausea and might consider the information to decide
on appropriate antiemetic treatment.
Since nausea was prevalent in the standard care group and nausea
may be associated with a reduced quality of life [1,33] treatment using
verum or sham acupuncture may be valuable and cost-effective since
positive effects do occur. A crude calculation of the cost for providing
the median number of 11 verum or sham sessions lasting 30 minutes
each results in a mean cost per patient of $69 USD. Two patients
(median) were treated at the same time, meaning that one patient
consumed three therapist hours*. In comparison, the approximate
costs of the recommended dose [6] of 8 mg of a serotonin-receptor
antagonists once per day during the radiotherapy period is $98 USD**.
Emesis was measured using a well-established method [17]. The
standard care cohort rated emesis only once, covering the
preceding week. Some patients in the standard care cohort may,
by forgetfulness, have underreported emesis, compared to the
acupuncture cohort, who rated emesis daily. The acupuncture
cohort was compared with a reference group, not to a third
randomized arm. That design requires for a thorough investiga-
tion of potential imbalance of confounding factors between groups,
as discussed above, but the design may have the benefit of avoiding
the impact of the data collection per se on reported emesis.
Repeated measurement of emesis per se may reduce (through the
so called Hawthorne effect) or increase emesis experience [34].
Young and co-workers found that emesis questions per se
increased self-reported occurrence of nausea [34]. To pay extra
attention to emesis through daily data collection, without
performing any extra emesis-reducing treatment in this frail
patient cohort, was therefore evaluated as being unethical. We
presented a cross sectional comparison at the time when the mean
radiotherapy dose was the same in the acupuncture and the
standard care cohorts. If we instead had observed another week of
the radiotherapy period, it would not have changed the
conclusions of this study; the weekly proportion of patients
experiencing nausea was lower in the acupuncture cohort all
radiotherapy weeks (varied 22 to 44% as described previously [13])
compared to the standard care cohort. The patients who were
treated by verum or sham experienced close to 50% lower
occurrence of emesis compared to the patients receiving standard
care. If the extra care caused the emesis reduction, this indicates
that as long as the best available antiemetic treatment is offered,
patients who believe that acupuncture has beneficial effects may be
satisfied with treatment with verum acupuncture or non-
penetrating needles, either of which produces a moment of
relaxation and attention from the therapist. A next obvious step is
to further study what components in the acupuncture procedures
are of importance for this dramatically positive but as yet not fully
understood effect, in an effort to make possible the use of those
components to further increase quality of care.
* A public hospital employing a physiotherapist for three hours
spends $68 USD (408 SEK to provide the mean salary value for
that service according to Swedish Association of Registered
Physiotherapists 2007, www.valuta.se, date 080404). Costs for
needles may be approximately $0.72 USD (24 needles consumed
during 12 sessions, at six US cents according to prices at www.
acuprime.com, date 101109).
** Consuming one tablet at a cost of 16.25 SEK (www.fass.se)
during the mean value of 36 radiotherapy days in treatment costs
$98 USD (based on cost in Sweden of 850 SEK www.valuta.se,
date 101109).
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